D'Onofrio Matthew J 4
4 · Evoke Pharma Inc · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-08+25,000→ 25,000 totalExercise: $4.01Exp: 2033-02-07→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The total number of shares of common stock subject to the option vests on the four-year anniversary of the date of grant, subject to the reporting person's continuous service to the issuer on such vesting date.